Dentons US LLP has advised SAB Biotherapeutics, Inc. on the transaction, and WilmerHale has advised RA Capital Management as lead investor. SAB BIO (Nasdaq: SABS), a...
Dentons US LLP has advised SAB Biotherapeutics, Inc. on the transaction, and WilmerHale has advised RA Capital Management as lead investor. SAB BIO (Nasdaq: SABS), a...
